Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers

BACKGROUND: “Udenafil” is a phosphodiesterase-5 inhibitor indicated for erectile dysfunction. “Dapoxetine” is a serotonin transport inhibitor indicated for premature ejaculation. The aim of the study reported here was to investigate the pharmacokinetic drug interaction between udenafil and dapoxetin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yo Han, Choi, Hee Youn, Lee, Shi Hyang, Jeon, Hae Sun, Lim, Hyeong-Seok, Bahng, Mi Young, Bae, Kyun-Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346016/
https://www.ncbi.nlm.nih.gov/pubmed/25759565
http://dx.doi.org/10.2147/DDDT.S78713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346016/
https://www.ncbi.nlm.nih.gov/pubmed/25759565
http://dx.doi.org/10.2147/DDDT.S78713

Ejemplares similares